S&P Futures
3,773.25 -16.25 (-0.43%) Dow Futures
30,652.00 -129.00 (-0.42%) Nasdaq Futures
11,465.00 -64.50 (-0.56%) Russell 2000 Futures
1,699.30 -8.70 (-0.51%) Crude Oil
108.39 +2.63 (+2.49%) Gold
1,789.20 -18.10 (-1.00%)
Precigen, Inc. (PGEN)
After hours:
- PR Newswire
Precigen to Participate in the Stifel 2022 Virtual Cell Therapy Summit
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a virtual panel discussion titled, "Targeted T Cell Therapies, Including Autologous CAR T, TCR and More" on Thursday, June 30, 2022, at 1:00 PM ET at the Stifel 2022 Virtual Cell Therapy Summit.
- PR Newswire
Precigen to Participate in the 2022 H.C. Wainwright Global Investment Conference
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a virtual fireside chat at the 2022 H.C. Wainwright Global Investment Conference. A webcast of the event will be available beginning at 7:00 AM ET on Tuesday, May 24, 2022.
- Simply Wall St.
Need To Know: Analysts Are Much More Bullish On Precigen, Inc. (NASDAQ:PGEN) Revenues
Shareholders in Precigen, Inc. ( NASDAQ:PGEN ) may be thrilled to learn that the analysts have just delivered a major...
